A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing

Ohm, Joyce E, McGarvey, Kelly M, Yu, Xiaobing, Cheng, Linzhao, Schuebel, Kornel E, Cope, Leslie, Mohammad, Helai P, Chen, Wei +9 more·2007·Nature Genetics

Cited by (1,000)

Items 701–800 of 1,000

  1. Integrative epigenome analysis identifies a Polycomb-targeted differentiation program as a tumor-suppressor event epigenetically inactivated in colorectal cancer
    Jing Ying Tan, Xiaojing Yang, Xia Jiang, Jianbiao Zhou, Zhuocheng Li, P L Lee, Baojie Li, Paul Robson, Qiang Yu · 2014 · Cell Death and Disease
  2. Nitric oxide inhibits ten-eleven translocation DNA demethylases to regulate 5mC and 5hmC across the genome
    Marianne B. Palczewski, Hannah Petraitis Kuschman, Brian M. Hoffman, Venkatesan Kathiresan, Hao Yang, Sharon Anneve Glynn, David L. Wilson, Eric T. Kool, W.R. Montfort, Jenny C. Chang et al. · 2025 · Nature Communications
  3. Chromatin: a molecular interface between cancer and aging
    Hazel A. Cruickshanks, Peter D. Adams · 2010 · Current Opinion in Genetics & Development
  4. DNA Methylation Profiling in Acute Myeloid Leukemia: From Recent Technological Advances to Biological and Clinical Insights
    Rainer Claus, Christoph Plass, Scott A. Armstrong, Lars Bullinger · 2010 · Future Oncology
  5. Prognostic value of aldh1, ezh2 and ki-67 in astrocytic gliomas
    Shimaa Abdallah Ahmed, Hayam E. Rashed, Abdelmonem Awad Hegazy, Abdel Motaleb Mohamed, Wael Abd Elrahman Ali Elmesallamy · 2016 · Turkish Journal of Pathology
  6. Epigenetics of Solid Cancer Stem Cells
    Alok Mishra, Mukesh Verma · 2012 · Methods in molecular biology
  7. Medulloblastoma epigenetics and the path to clinical innovation
    Amanda R. Haltom, Stephanie A. Toll, Donghang Cheng, Shinji Maegawa, Vidya Gopalakrishnan, Soumen Khatua · 2020 · Journal of Neuro-Oncology
  8. DNA-methylation for the detection and distinction of 19 human malignancies
    Ludmila Danilova, John M. Wrangle, James Gordon Herman, Leslie Cope · 2021 · Epigenetics
  9. Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth
    Qiang Li, Mark E. O’Malley, David L. Bartlett, Sheng Guo · 2011 · Molecular Cancer
  10. Predictive Factors for Outcome and Quality of Life in HPV-Positive and HPV-Negative HNSCC
    Jochen Heß · 2016 · Recent results in cancer research/Recent Results in Cancer Research
  11. Epigenetic silencing during early lineage commitment
    Bergman · 2009 · StemBook
  12. DNA methylation programming and reprogramming in primate embryonic stem cells
    Netta Mendelson Cohen, Vikas D. Dighe, Gilad Landan, Sigrún Reynisdóttir, Arnar Pálsson, Shoukhrat M. Mitalipov, Amos Tanay · 2009 · Genome Research
  13. The Dynamics of Global Chromatin Remodeling are Pivotal for Tracking the Normal Pluripotency of Human Embryonic Stem Cells Xuejun H. Parsons
    Xuejun H. Parsons · 2012 · Anatomy & Physiology
  14. Isoform switching and exon skipping induced by the DNA methylation inhibitor 5-Aza-2′-deoxycytidine
    Xiaolei Ding, Xiaojing Yang, Gangning Liang, Kai Wang · 2016 · Scientific Reports
  15. Hyperactive DNA Cutting for Unbiased UHPLC–MS/MS Quantification of Epigenetic DNA Marks by Engineering DNase I Mutants
    Xingrui Song, Xinyue Song, Weiyi Lai, Hailin Wang · 2022 · Analytical Chemistry
  16. Epigenetic alterations affecting hematopoietic regulatory networks as drivers of mixed myeloid/lymphoid leukemia
    Roger Mulet‐Lazaro, Stanley van Herk, Margit Nuetzel, Anikó Sijs‐Szabó, Noèlia Díaz, Katherine Kelly, Claudia A. J. Erpelinck-Verschueren, Lucia Schwarzfischer, Hanna Stanewsky, Ute Ackermann et al. · 2024 · Nature Communications
  17. Genome‐wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features
    Anna Enjuanes, Robert Alberó, Guillem Clot, Alba Navarro, Sı́lvia Beà, Magda Pinyol, José Ignacio Martín-Subero, Wolfram Klapper, Louis M. Staudt, Elaine S. Jaffe et al. · 2013 · International Journal of Cancer
  18. Reprogramming of mesenchymal stem cells by oncogenes
    Josiane E. Eid, Christina B. Garcia · 2014 · Seminars in Cancer Biology
  19. Downregulation of miR‐326 and its host gene β‐arrestin1 induces pro‐survival activity of E2F1 and promotes medulloblastoma growth
    Evelina Miele, Agnese Pò, Angela Mastronuzzi, Andrea Carai, Zein Mersini Besharat, Natalia Pediconi, Luana Abballe, Giuseppina Catanzaro, Claudia Sabato, Enrico De Smaele et al. · 2020 · Molecular Oncology
  20. Impact of gene expression profiling in lymphoma diagnosis and prognosis
    Christopher Orsborne, Richard J. Byers · 2011 · Histopathology
  21. Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma
    Junxia Lei, Songlin Chen, Shuping Zhong · 2017 · Liver Research
  22. Alternative models for transgenerational epigenetic inheritance: Molecular psychiatry beyond mice and man
    Gary R. Hime, Sophie LA Stonehouse, Terence Y. Pang · 2021 · World Journal of Psychiatry
  23. The role of chromatin, microRNAs, and tumor stem cells in ovarian cancer
    Curtis Balch, Kenneth P. Nephew · 2011 · Cancer Biomarkers
  24. Genome-Wide Promoter Methylome of Small Renal Masses
    Ilsiya Ibragimova, Michael J. Slifker, Marie E. Maradeo, Banumathy Gowrishankar, Essel Dulaimi, Robert G. Uzzo, Paul Cairns · 2013 · PLoS ONE
  25. Epigenetic Targeting of Platinum Resistant Testicular Cancer
    Daniel Sonnenburg, Michael J. Spinella, Costantine Albany · 2016 · Current Cancer Drug Targets
  26. Acquired Genetic and Epigenetic Alterations in Nasopharyngeal Carcinoma
    Kwok Wai Lo, Grace Tin‐Yun Chung, Ka‐Fai To · 2013 · Advances in experimental medicine and biology
  27. Correction: CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells
    Xiaojing Yang, Radha Krishna Murthy Karuturi, Feng Sun, Meiyee Aau, Kun Yu, Rong‐Guang Shao, Lance David Miller, Patrick Boon Ooi Tan, Qiang Yu · 2009 · PLoS ONE
  28. Effects of genome architecture and epigenetic factors on susceptibility of promoter CpG islands to aberrant DNA methylation induction
    Hideyuki Takeshima, Satoshi Yamashita, Taichi Shimazu, Toshikazu Ushijima · 2011 · Genomics
  29. Epigenetic Codes in Stem Cells and Cancer Stem Cells
    Yasuhiro Yamada, Akira Watanabe · 2010 · Advances in genetics
  30. Aberrant DNA Methylation in ES Cells
    Guy Ludwig, Deborah Nejman, Merav Hecht, Shari Orlanski, Monther Abu-Remaileh, Ofra Yanuka, Oded Sandler, Amichai Marx, Douglas N. Roberts, Nissim Benvenisty et al. · 2014 · PLoS ONE
  31. Long range epigenetic silencing is a trans‐species mechanism that results in cancer specific deregulation by overriding the chromatin domains of normal cells
    Marta Forn, Mar Muñoz, Daniele V. F. Tauriello, Anna Merlos‐Suárez, Verónica Rodilla, Anna Bigas, Eduard Batlle, Mireia Jordà, Miguel Angel Peinado · 2013 · Molecular Oncology
  32. Concurrent IDH1 and SMARCB1 Mutations in Pediatric Medulloblastoma: A Case Report
    Moatasem El‐Ayadi, Kristof Levente Egervari, Doron Merkler, Thomas McKee, Fabienne Gumy‐Pause, Damian Stichel, David Capper, Torsten Pietsch, Marc Ansari, Andre Oscar von Bueren · 2018 · Frontiers in Neurology
  33. DNA methylation determines the regulation of pregnane X receptor on CYP3A4 expression
    Xiaofei Wang, Luman Wei, Jingke Yang, Yiting Wang, Shitong Chen, Kun Yang, Xiangguang Meng, Lirong Zhang · 2020 · Clinical and Experimental Pharmacology and Physiology
  34. Charting differentially methylated regions in cancer with Rocker-meth
    Matteo Benelli, Gian Marco Franceschini, Alberto Magi, Dario Romagnoli, Chiara Biagioni, Ilenia Migliaccio, Luca Malorni, Francesca Demichelis · 2021 · Communications Biology
  35. Epigenomic Characterization of Lymphoid Neoplasms
    Martí Duran‐Ferrer, José Ignacio Martín-Subero · 2023 · Annual Review of Pathology Mechanisms of Disease
  36. Antiproliferative Effects of DNA Methyltransferase 3B Depletion Are Not Associated with DNA Demethylation
    Sabine Hagemann, Dirk Kuck, Carlo Stresemann, Florian Prinz, Bodo Brueckner, Cora Mund, Dominik Mumberg, Anette Sommer · 2012 · PLoS ONE
  37. Impact of human MLL/COMPASS and polycomb complexes on the DNA methylome
    Emily L. Putiri, Rochelle L. Tiedemann, Chunsheng Liu, Jeong-Hyeon Choi, Keith D. Robertson · 2014 · Oncotarget
  38. The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent
    Carmen Brenner, Judith Luciani, Martin Bizet, ’Matladi N. Ndlovu, Eléonore Josseaux, Sarah Dedeurwaerder, Emilie Calonne, Pascale Putmans, Pierre‐François Cartron, Matthieu Defrance et al. · 2016 · Oncotarget
  39. CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies
    Francisco Sánchez-Vega, Valer Gotea, Yun-Ching Chen, Laura L. Elnitski · 2017 · World Journal of Gastrointestinal Oncology
  40. Multiplatform Molecular Profiling Reveals Epigenomic Intratumor Heterogeneity in Ependymoma
    S. Liu, S. Magill, H. Vasudevan, S. Hilz, Javier E. Villanueva-Meyer, S. Lastella, V. Daggubati, J. Spatz, A. Choudhury, Brent A. Orr et al. · 2020 · Cell Reports
  41. Epigenetics makes its mark on women-specific cancers—an opportunity to redefine oncological approaches?
    Martin Widschwendter, Allison Jones, Andrew Erich Teschendorff · 2012 · Gynecologic Oncology
  42. MetMap Enables Genome-Scale Methyltyping for Determining Methylation States in Populations
    Meromit Singer, Dario Boffelli, Joseph M. Dhahbi, Alexander Schönhuth, Gary P. Schroth, David I. K. Martin, Lior S. Pachter · 2010 · PLoS Computational Biology
  43. Folic Acid Functionalized Surface Highlights 5‐Methylcytosine‐Genomic Content within Circulating Tumor Cells
    Natalia Malara, Maria Laura Coluccio, Tania Limongi, Monica Asande, Valentina Trunzo, Gheorghe Cojoc, Cinzia Raso, Patrizio Candeloro, Gerardo Perozziello, Raffaella Raimondo et al. · 2014 · Small
  44. Deregulated Polycomb functions in myeloproliferative neoplasms
    Goro Sashida, Motohiko Oshima, Atsushi Iwama · 2019 · International Journal of Hematology
  45. Transcription factor expression repertoire basis for epigenetic and transcriptional subtypes of colorectal cancers
    Yuba R. Bhandari, Vinod Krishna, Rachael Powers, Sehej Parmar, Sara-Jayne Thursby, Ekta Gupta, Ozlem Kulak, Prashanth Ravishankar Gokare, Joke Reumers, Liesbeth Van Wesenbeeck et al. · 2023 · Proceedings of the National Academy of Sciences
  46. Differential responses to genotoxic agents between induced pluripotent stem cells and tumor cell lines
    Yinghua Lu, Dazhong Xu, Jing Zhou, Yupo Ma, Yongping Jiang, Wenxian Zeng, Wei Hao Dai · 2013 · Journal of Hematology & Oncology
  47. Role of Enhancer of Zeste Homolog 2 Polycomb Protein and Its Significance in Tumor Progression and Cell Differentiation
    Irene Marchesi, Luigi Bagell · 2013 · InTech eBooks
  48. Zebrafish Discoveries in Cancer Epigenetics
    Yelena Chernyavskaya, Brandon Kent, Kirsten C. Sadler · 2016 · Advances in experimental medicine and biology
  49. Nocturia and obstructive sleep apnoea
    Olaf P. J. Vrooman, Philip Van Kerrebroeck, Michael R. van Balken, Gommert Anton van Koeveringe, Mohammad Sajjad Rahnama’i · 2024 · Nature Reviews Urology
  50. Epigenetics of cell fate reprogramming and its implications for neurological disorders modelling
    Maciej Grzybek, Aleksandra Golonko, Marta Walczak, Paweł Lisowski · 2016 · Neurobiology of Disease
  51. Embedding the Future of Regenerative Medicine into the Open Epigenomic Landscape of Pluripotent Human Embryonic Stem Cells.
    Xuejun H. Parsons · 2013 · Annual Research & Review in Biology
  52. Epithelial–Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma
    Kanlayanee Sawanyawisuth, Goro Sashida, Guojun Sheng · 2021 · Cancers
  53. Cancer Stem Cells are Actually Stem Cells with Disordered Differentiation: the Monophyletic Origin of Cancer
    Qiankun Luo, Pan Liu, Pengfei Yu, Tao Qin · 2023 · Stem Cell Reviews and Reports
  54. Alternatively spliced MEFV transcript lacking exon 2 and its protein isoform pyrin-2d implies an epigenetic regulation of the gene in inflammatory cell culture models
    Gökçe Çelikyapi Erdem, Sule Erdemir, İrem Abacı, Aslı Kireçtepe Aydın, Elif Everest, Eda Tahir Turanlı · 2017 · Genetics and Molecular Biology
  55. Chromatin Bottlenecks in Cancer
    Jay F. Sarthy, Steven Henikoff, Kami Ahmad · 2019 · Trends in cancer
  56. Modifications of H3K4 methylation levels are associated with DNA hypermethylation in acute myeloid leukemia
    Stefania Scalea, Carmen Maresca, Caterina Catalanotto, Rachele Marino, Carlo Cogoni, Anna Reale, Michele Zampieri, Giuseppe Zardo · 2019 · FEBS Journal
  57. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer
    Xiaoge Ni, Can Chen, Guoliang Cui, Weifeng Ding, Jinhui Liu · 2022 · Frontiers in Immunology
  58. Role of Nuclear Architecture in Epigenetic Alterations in Cancer
    Hariharan Easwaran, Stephen B. Baylin · 2010 · Cold Spring Harbor Symposia on Quantitative Biology
  59. Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal‐like Breast Cancer
    Jiahui Zhang, Nanyan Miao, Liyan Lao, Wen Deng, Jiawen Wang, Xiao‐Feng Zhu, Yongsheng Huang, Huayue Lin, Wenfeng Zeng, Wei Zhang et al. · 2024 · Advanced Science
  60. On correlative and causal links of replicative epimutations
    Wanding Zhou, Yitzhak Reizel · 2024 · Trends in Genetics
  61. DNA methylation in melanoma immunotherapy: mechanisms and therapeutic opportunities
    Maya G. Deshmukh, Veronica T. Brooks, Simon F. Roy, Simon Milette, Marcus Bosenberg, Goran Micevic · 2025 · Clinical Epigenetics
  62. The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something?
    Margaret Ottaviano, Emilio Francesco Giunta, Pasquale Rescigno, Ricardo Pereira Mestre, Laura Marandino, Marianna Tortora, Vittorio Riccio, Sara Parola, Milena Casula, Panagiotis Paliogiannis et al. · 2021 · International Journal of Molecular Sciences
  63. Epigenetics in cancer development, diagnosis and therapy
    Dinh‐Toi Chu, Anh-Dao Ngo, Chia‐Ching Wu · 2023 · Progress in molecular biology and translational science
  64. Deficiency of the Polycomb Protein RYBP and TET Methylcytosine Oxidases Promotes Extensive CpG Island Hypermethylation and Malignant Transformation
    Wei Cui, Zhijun Huang, Seung‐Gi Jin, Jennifer S. Johnson, Kin H. Lau, Galen H. Hostetter, Gerd P. Pfeifer · 2023 · Cancer Research
  65. Epigenetic Subgroups of Esophageal and Gastric Adenocarcinoma with Differential GATA5 DNA Methylation Associated with Clinical and Lifestyle Factors
    Xinhui Wang, Gyeong Hoon Kang, Mihaela Campan, Daniel J. Weisenberger, Tiffany I. Long, Wendy Cozen, Leslie Bernstein, Anna H. Wu, Kimberly D. Siegmund, Darryl K. Shibata et al. · 2011 · PLoS ONE
  66. Remodeling Genomes with Artificial Transcription Factors (ATFs)
    Adriana S. Beltrán, Pilar Blancafort · 2010 · Methods in molecular biology
  67. Astrocyte ethanol exposure reveals persistent and defined calcium response subtypes and associated gene signatures
    Hyun-Bum Kim, Youtao Lu, Seonkyung C. Oh, Jacqueline F. Morris, Kevin Miyashiro, Junhyong Kim, James H. Eberwine, Jai‐Yoon Sul · 2022 · Journal of Biological Chemistry
  68. ENSA expression correlates with attenuated tumor propagation in liver cancer
    Yao-Li Chen, Ming-Han Kuo, Ping-Yi Lin, Wan-Ling Chuang, Chia‐Chen Hsu, Pei‐Yi Chu, Chia‐Huei Lee, Tim H.‐M. Huang, Yu‐Wei Leu, Shu‐Huei Hsiao · 2013 · Biochemical and Biophysical Research Communications
  69. Emerging Evidence for MicroRNAs as Regulators of Cancer Stem Cells
    Aisha Sethi, Lynette Marie Sholl · 2011 · Cancers
  70. Epigenetics and Ovarian Cancer
    Kenneth P. Nephew, Curt Balch, Shu Zhang, Tim H.‐M. Huang · 2009 · Cancer treatment and research
  71. DNA methylation of polycomb group target genes in cores taken from breast cancer centre and periphery
    Evangelia-O Fourkala, Cornelia Hauser‐Kronberger, Sophia Apostolidou, Matthew Burnell, Allison Jones, Johannes Grall, Roland Reitsamer, Heidi Fiegl, Ian J. Jacobs, Usha Menon et al. · 2009 · Breast Cancer Research and Treatment
  72. Epigenetic Modulation and Brain Function in Parkinson's Disease: The Role of Exercise Alone or Combined With Polyphenols
    Xuenan Cao, Xiantao Cui, Bita Badehnoosh · 2025 · Food Science & Nutrition
  73. Epigenetic modulators for brain cancer stem cells: Implications for anticancer treatment
    Luana Abballe, Evelina Miele · 2021 · World Journal of Stem Cells
  74. Histone Modifications in Cancer Biology and Prognosis
    Siavash K. Kurdistani, David B. Seligson, Matthew A. McBrian · 2008 · CRC Press eBooks
  75. Physical Chemistry of Epigenetics: Single-Molecule Investigations
    Tae-Hee Lee · 2019 · The Journal of Physical Chemistry B
  76. Methods for genome-wide analysis of DNA methylation in intestinal tumors
    Maria A. Hahn, Gerd P. Pfeifer · 2009 · Mutation research. Fundamental and molecular mechanisms of mutagenesis
  77. Insights Into the Role of Bmi‐1 Deregulation in Promoting Stemness and Therapy Resistance in Glioblastoma: A Narrative Review
    Fatima Shaalan, Nissrine Ballout, Wafaa Takash Chamoun · 2025 · Cancer Medicine
  78. Systematic identification of regions where DNA methylation is correlated with transcription refines regulatory logic in normal and tumour tissues
    Richard Heery, Martin H. Schaefer · 2025 · Nucleic Acids Research
  79. Methylation of the Tumor Suppressor Genes HIC1 and RassF1A Clusters Independently From the Methylation of Polycomb Target Genes in Colon Cancer
    Hong-Chang Chen, Hsuan-Yuan Huang, Yao-Li Chen, Kuan‐Der Lee, Yi-Ru Chu, Ping-Yi Lin, Chia‐Chen Hsu, Pei‐Yi Chu, Tim H.‐M. Huang, Shu‐Huei Hsiao et al. · 2015 · Annals of Surgical Oncology
  80. The putative tumor suppressor gene EphA7 is a novel BMI-1 target
    Gaëlle Prost, Sebastian Benedict Braun, Falk Hertwig, Marcus Winkler, Lucas Jagemann, Sara Nolbrant, Isabelle V. Leefa Chong San, Nils Offen, Kenichi Miharada, Stefan Lang et al. · 2016 · Oncotarget
  81. Stem cells and colorectal carcinogenesis.
    Marilena Stoian, Stoica, G. Radulian · 2016 · PubMed Central · Retracted
  82. Targeting Epigenetic Dependencies in Solid Tumors: Evolutionary Landscape Beyond Germ Layers Origin
    Francesca Citron, Linda Fabris · 2020 · Cancers
  83. Epigenetics and its Therapeutic Potential in Colorectal Cancer
    Mahsa Akbari Oryani, Afsaneh Tavasoli, Mohammad Amin Ghalavand, Rahele Zokaei Ashtiani, Alisam Rezaee, Rasadokht Mahmoudi, Hossein Golvari, Soroor Owrangi, Mehdi Soleymani-Goloujeh · 2022 · Epigenomics
  84. Drosophila and the Hallmarks of Cancer
    Theodoulakis Christofi, Yiorgos Apidianakis · 2013 · Advances in biochemical engineering, biotechnology
  85. Association between DNA methylation profile and malignancy in follicular-patterned thyroid neoplasms
    Ornella Affinito, Paolo Salerno, Alfonso Manuel D’Alessio, Mariella Cuomo, Ermanno Florio, Francesca Carlomagno, Agnese Proietti, Riccardo Giannini, Fulvio Basolo, Lorenzo Chiariotti et al. · 2019 · Endocrine Related Cancer
  86. Epigenetics in Myeloid Malignancies
    Stefan Deneberg · 2012 · Methods in molecular biology
  87. Pan-cancer analysis revealed H3K4me1 at bivalent promoters premarks DNA hypermethylation during tumor development and identified the regulatory role of DNA methylation in relation to histone modifications
    Lu Yang, Qiang Cao, Yue Yu, Yazhou Sun, Xuan Jade Jiang, Xin Li · 2023 · BMC Genomics
  88. TRIM28-dependent developmental heterogeneity determines cancer susceptibility through distinct epigenetic states
    Ilaria Panzeri, Luca Fagnocchi, Stefanos Apostle, Megan Tompkins, Emily Wolfrum, Zachary Madaj, Galen H. Hostetter, Yanqing Liu, Kristen Schaefer, Chih-Hsiang Yang et al. · 2025 · Nature Cancer
  89. Chromatin Remodulator CHD4: A Potential Target for Cancer Interception
    Krishnendu Goswami, Karthikkumar Venkatachalam, Surya Pratap Singh, Chinthalapally V. Rao, Venkateshwar Madka · 2025 · Genes
  90. Investigating DNA Methylation Dynamics and Safety of Human Embryonic Stem Cell Differentiation Toward Striatal Neurons
    Simona Baronchelli, Alberto Spada, Paola Conforti, Serena Redaelli, Leda Dalprà, Pasquale De Blasio, Elena F. Cattaneo, Ida Biunno · 2015 · Stem Cells and Development
  91. Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK–driven lymphomagenesis
    Elisa Redl, Raheleh Sheibani‐Tezerji, Crhistian de Jesus Cardona, Patricia Hamminger, Gerald Timelthaler, Melanie R. Hassler, Maša Zrimšek, Sabine Lagger, Thomas Dillinger, Lorena Hofbauer et al. · 2020 · Life Science Alliance
  92. Nucleosome Occupancy and Gene Regulation During Tumorigenesis
    Claudia Andreu‐Vieyra, Gangning Liang · 2012 · Advances in experimental medicine and biology
  93. DNA Methylation and Hydroxymethylation in Cancer
    Fazila Asmar, Alexandra Søgaard Helbo, Kirsten Grønbæk · 2015 · Elsevier eBooks
  94. Identification of epigenetic modifications that contribute to pathogenesis in therapy-related AML: Effective integration of genome-wide histone modification with transcriptional profiles
    Xinan Holly Yang, Bin Wang, John M. Cunningham · 2015 · BMC Medical Genomics
  95. Epigenetics—an emerging and highly promising source of new drug targets
    Nessa Carey · 2011 · MedChemComm
  96. Embryonic Stem Cell (ES)-Specific Enhancers Specify the Expression Potential of ES Genes in Cancer
    Dvir Aran, Monther Abu-Remaileh, Revital Levy, Nurit Meron, Gidon Toperoff, Yifat Edrei, Yehudit Bergman, Asaf Hellman · 2016 · PLoS Genetics
  97. Cancer and Aging
    Craig A. Cooney · 2008 · CRC Press eBooks
  98. DAMD to epigenetic silence
    T. Kelly, Peter A. Jones · 2009 · Proceedings of the National Academy of Sciences
  99. Tissue-Based Diagnostic Biomarkers of Aggressive Variant Prostate Cancer: A Narrative Review
    Olga Kouroukli, Vasiliki Bravou, Konstantinos Giannitsas, Vassiliki Tzelepi · 2024 · Cancers
  100. Polycomb group proteins in hematopoietic stem cell aging and malignancies
    Karin Klauke, Gerald de Haan · 2011 · International Journal of Hematology